Planet 13 Holdings (PLNH) Operating Leases (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Operating Leases came in at $42.9 million in Q1 2026, down 10.47% year-on-year from $47.9 million in Q1 2025, and down 3.83% on a QoQ basis from $44.6 million in Q4 2025.
Planet 13 Holdings (PLNH) Operating Leases (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Operating Leases data on file, last reported at $42.9 million in Q1 2026.
- On a quarterly basis, Operating Leases fell 10.47% year-over-year to $42.9 million in Q1 2026; TTM through Mar 2026 was $42.9 million, a 10.47% decrease from a year earlier, with the FY2025 full-year figure at $44.6 million, down 3.98% from the prior year.
- Operating Leases for Q1 2026 stood at $42.9 million, down from $44.6 million in the prior quarter.
- Over the last five years, Operating Leases for PLNH reached as high as $48.2 million in Q3 2025 and fell as low as $25.3 million in Q4 2023.
- Historically, Operating Leases has averaged $35.6 million across 5 years, with a median of $26.7 million in 2023.
- Across the five-year window, Operating Leases jumped 83.8% in 2024 and fell 10.47% in 2026, its largest moves.
- Year by year, Operating Leases stood at $26.3 million in 2022, then slipped by 3.95% to $25.3 million in 2023, then soared by 83.8% to $46.4 million in 2024, then declined by 3.98% to $44.6 million in 2025, then fell by 3.83% to $42.9 million in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $42.9 million in Q1 2026, $44.6 million in Q4 2025, and $48.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.89 Mn |
| Dec 31, 2025 | 44.60 Mn |
| Sep 30, 2025 | 48.20 Mn |
| Jun 30, 2025 | 48.07 Mn |
| Mar 31, 2025 | 47.90 Mn |
| Dec 31, 2024 | 46.45 Mn |
| Sep 30, 2024 | 45.70 Mn |
| Jun 30, 2024 | 45.91 Mn |
| Mar 31, 2024 | 26.58 Mn |
| Dec 31, 2023 | 25.27 Mn |
| Sep 30, 2023 | 26.66 Mn |
| Jun 30, 2023 | 26.74 Mn |
| Mar 31, 2023 | 25.95 Mn |
| Dec 31, 2022 | 26.31 Mn |
| Sep 30, 2022 | 26.31 Mn |
| Jun 30, 2022 | 26.31 Mn |
| Mar 31, 2022 | 25.83 Mn |
| Dec 31, 2021 | 23.56 Mn |
| Mar 31, 2021 | 23.56 Mn |